Volume 49 No 2 - Oncology

Original Articles

Ma. Pamela D. Patdu

The Effect of DOH-PCSI Patient Navigation Access Program for Breast Cancer on Quality of Care at the Medical Oncology Clinic at the Philippine General Hospital: The 1st 6 Months

Ma. Pamela D. Patdu, Wilfredo L. Liangco, Corazon A. Ngelangel, Anna Melissa S. Guerrero, Ma. Victoria G. Ala, Rachel Marie B. Rosario and Romeo V. Marcaida

Marie Christine G. Semira

Impact of Histopathological Profile on Disease Progression of Breast Cancer Patients during the 1st 1-2 Years follow-up: Evidence from the Philippine DOH-Breast Cancer Medicine Access Program

Marie Christine G. Semira, Joanne Marie L. Balbuena, Vanina Htun-Javier, Jennifer Sandoval-Tan, Corazon A. Ngelangel, Anna Melissa S. Guerrero, Rachel Marie B. Rosario and Romeo V. Marcaida

Immunohistochemical Profile, Pattern of Recurrence, and Time to Progression of Non-Metastatic Breast Cancer Patients of the Department of Health-Breast Cancer Medicines Access Program

Nelson A. Laja, Arthur Gregory A. Lui, Joar Kent P. Gumapon, Corazon A. Ngelangel, Anna Melissa S. Guerrero, Dennis L. Sacdalan, Rachel Marie B. Rosario and Romeo V. Marcaida

Lou Jorel P. Tia

Chemotherapy-Induced Neutropenia, Anemia and Thrombocytopenia among Filipino Breast Cancer Patients on Adjuvant Chemotherapy

Lou Jorel P. Tia, Arthur Gregory A. Lui, Noel S. Chua and Heinrik Martin Jude S. Strebel

Mary Ondinee U. Manalo

Correlation between Demographic, Socio-economic, and Cancer-specific Factors with Quality of Life Scores among Newly-Diagnosed Cancer Patients of the Medical Oncology Clinics of the Philippine General Hospital Cancer Institute

Mary Ondinee U. Manalo and Corazon A. Ngelangel

Irisyl Orolfo-Real

Understanding Current Attitudes to HER2 Testing for Breast Cancer at Tertiary Referral Hospitals of Metro Manila, Philippines

Irisyl Orolfo-Real, Susano B. Tanael, Jose Ma C. Avila, Corazon A. Ngelangel and Ma. Lourdes A. Tiambeng

Marlowe S. Imperial

Specimen Handling and Tissue Preparation in Pre-analytical Phase of HER2 Testing at Tertiary Referral Hospitals of Metro Manila, Philippines

Marlowe S. Imperial, Susano B. Tanael, Jose Ma C. Avila and Ma. Lourdes A. Tiambeng

Ivy D. de Dios

Satisfaction in HER2 Testing among Medical Oncologists – Aiming for Multidisciplinary HER2 Testing in the Philippines

Ivy D. de Dios, Jerry Y. Tan Chun Bing, Susano B.Tanael, Corazon A. Ngelangel and Ma. Lourdes A. Tiambeng

Henri S. Co

Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision in the Management of Locally Advanced Rectal Carcinoma – The PGH CRPoCan Study Group Experience 2008-2009

Henri S. Co, Marie Dione P. Sacdalan, Marc J. Lopez, Irisyl O. Real, Mark C. Ang, Edilberto V. Fragante, Manuel T. Roxas, Dennis L. Sacdalan and Andrew D. Dimacali

Jerry Y. Tan Chun Bing

XELOX + Bevacizumab compared to FOLFOX4 + Bevacizumab in First line Metastatic Colorectal Cancer in a Non-reimbursed Health Care System: A Cost Analysis

Jerry Y. Tan Chun Bing, Andrew A. Yacat and Dennis L. Sacdalan

Mary Ondinee U. Manalo

Bevacizumab in HER2neu Negative Locally Recurrent and Metastatic Breast Cancer: The BHerN Review

Mary Ondinee U. Manalo, Mark Anthony E. Agana and Corazon A.Ngelangel

Sexual Dysfunction among Filipino Breast Cancer Patients

Arthur Gregory A. Lui, Joanne Marie L. Balbuena, Antonio L. Faltado Jr., Charles Vincent O. Uy and Heinrik Martin Jude S. Strebel

Case Series / Case Reports

Mary Ondinee U. Manalo

Primary Mediastinal Liposarcoma of the Superior, Middle, and Anterior Mediastinum

Mary Ondinee U. Manalo and Gracieux Y. Fernando

Back to Top